MedTrace Logo

Assessment of OSA in Latin American and Response to Neuromod Therapy

NCT06762873 · Status: RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-09-03

No results posted yet for this study

Summary

The purpose of this study is to characterize the upper airway of Latin American subjects who have been diagnosed with moderate/severe obstructive sleep apnea (OSA) and assess response to a neuromodulation therapy to treat OSA.

Conditions

Interventions

DIAGNOSTIC_TEST

Drug Induced Sleep Endoscopy with PNS

Enrolled subjects will complete an overnight PSG and then undergo a DISE procedure with a 30-minute research period.

Sponsors & Collaborators

  • Lunair Medical

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-21
Primary Completion
2024-12-31
Completion
2025-12-31

Countries

  • Paraguay

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06762873 on ClinicalTrials.gov